Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer

Similar Items

• The Application of Real-Time PCR Technique to Detect Rare Cell Clones with Primary T790M Substitution of EGFR Gene in Metastases of Non-small Cell Lung Cancer to Central Nervous System in Chemotherapy Naive Patients
  od: Powrózek, Tomasz, i dr.
  Izdano: (2014)
• Letter to the editor concerning first-line therapy with afatinib – an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations
  od: Krawczyk, Paweł, i dr.
  Izdano: (2015)
• Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
  od: Nicoś, Marcin, i dr.
  Izdano: (2019)
• The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
  od: Krawczyk, Paweł, i dr.
  Izdano: (2013)
• Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer
  od: Szczyrek, Michał, i dr.
  Izdano: (2016)